title: Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naïve patients in the acute phase after TIA or minor ischaemic stroke.
authors.affiliation: Stroke Prevention Research Unit, Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK.
authors.forename: O C
authors.initials: OC
authors.lastname: Geraghty
authors.forename: J
authors.initials: J
authors.lastname: Kennedy
authors.forename: A
authors.initials: A
authors.lastname: Chandratheva
authors.forename: L
authors.initials: L
authors.lastname: Marquardt
authors.forename: A M
authors.initials: AM
authors.lastname: Buchan
authors.forename: P M
authors.initials: PM
authors.lastname: Rothwell
mesh_terms: D000368:Aged; D001241:Aspirin / Q000009:adverse effects* / Q000627:therapeutic use; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000517:prevention & control; D008137:Longitudinal Studies; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy* / Q000517:prevention & control; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin